Significance of Variants of Uncertain Significance: The Human Cost of Genetic Uncertainty

Damla Gonullu‐Rotman

DOI: https://doi.org/10.1002/ajmg.c.32109

2024-09-03

American Journal of Medical Genetics Part C Seminars in Medical Genetics

Abstract:American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.

genetics & heredity

What problem does this paper attempt to address?

The Biggest Struggle: Navigating Trust and Uncertainty in Genetic Variant Interpretation

Zachary Griffen,Dina M Asfaha,Kellie Owens

DOI: https://doi.org/10.1159/000542274

Public Health Genomics

Abstract:Introduction: As the utility of genomic sequencing increases, its use in healthcare will continue to expand beyond expert clinics toward nonspecialist practices such as primary care. At the same time, discordance in genetic variant identification and classification between laboratories remains a concern for the field. This research assesses how clinicians with and without genetics expertise understand and trust genetic test results, underscoring how variation in the handling of genetic test results can have real impact on patient care. Methods: We conducted 40 interviews with genetics experts, including clinical geneticists and genetic counselors, and nonexpert clinicians including primary care providers and cardiologists. Results: Clinical geneticists and genetic counselors reported spending significant time assessing the validity of results from genetic testing laboratories, conversing with laboratories about those results, and potentially reinterpreting results. Conversely, primary care providers and cardiologists without specific genetics expertise reported high levels of trust in laboratory accuracy and variant interpretation, and did not reassess results. Conclusion: We find significant variation in how genetics experts and nonexperts understand the trustworthiness of genetic laboratory reports. This variation could lead to differences in patient care between clinical settings and requires additional guidance for clinicians regarding the handling of genetic test results.
Family Lore, a Variant of Uncertain Significance, and CADASIL

Rhys Duarte,Liesbeth Vossaert,Sandra A. Darilek,Chelsi Rose,Evan Schauer,Christian Parobek,Emily Bland,Keren Machol,Elizabeth Mizerik,Chaya N. Murali

DOI: https://doi.org/10.1002/ajmg.c.32117

2024-10-22

American Journal of Medical Genetics Part C Seminars in Medical Genetics

Abstract:American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.

genetics & heredity
Variant scoring performance across selection regimes depends on variant-to-gene and gene-to-disease components

Hilary K. Finucane,Sophie Parsa,Jeremy Guez,Masahiro Kanai,F. Kyle Satterstrom,Lethukuthula L. Nkambule,Mark J. Daly,Cotton Seed,Konrad J. Karczewski

DOI: https://doi.org/10.1101/2024.09.17.613327

2024-09-19

Abstract:Variant scoring methods (VSMs) aid in the interpretation of coding mutations and their potential impact on health, but their evaluation in the context of human genetics applications remains inconsistent. Here, we describe GeneticsGym, a systematic approach to evaluating the real-world impact of VSMs on human genetic analysis. We show that the relative performance of VSMs varies across regimes of natural selection, and that both variant-to-gene and gene-to-disease components contribute.

Bioinformatics
Capturing All Disease-Causing Mutations for Clinical and Research Use: Toward an Effortless System for the Human Variome Project

Richard G H Cotton,Aida I Al Aqeel,Fahd Al-Mulla,Paola Carrera,Mireille Claustres,Rosemary Ekong,Valentine J Hyland,Finlay A Macrae,Makia J Marafie,Mark H Paalman,George P Patrinos,Ming Qi,Rajkumar S Ramesar,Rodney J Scott,Rolf H Sijmons,María-Jesús Sobrido,Mauno Vihinen

DOI: https://doi.org/10.1097/gim.0b013e3181c371c5

2009-01-01

Abstract:The collection of genetic variants that cause inherited disease (causative mutation) has occurred for decades albeit in an ad hoc way, for research and clinical purposes. More recently, the access to collections of mutations causing specific diseases has become essential for appropriate genetic health care. Because information has accumulated, it has become apparent that there are many gaps in our ability to correctly annotate all the changes that are being identified at ever increasing rates. The Human Variome Project (www.humanvariomeproject.org) was initiated to facilitate integrated and systematic collection and access to this data. This manuscript discusses how collection of such data may be facilitated through new software and strategies in the clinical genetics and diagnostic laboratory communities.
Germline Variants of Uncertain Significance in Gynecologic Oncology Patients

Julia Cooper,Leigha Senter

DOI: https://doi.org/10.1097/grf.0000000000000898

2024-10-22

Clinical Obstetrics & Gynecology

Abstract:Germline and somatic genetic/genomic testing are commonly ordered for gynecologic oncology patients. Genetic tests can inform disease etiology, prognosis, treatment decisions, and risk to the patient's relatives. Variants of uncertain significance (VUSs) are frequently encountered and have a more nuanced interpretation than straightforward pathogenic or benign variant classifications. Clinical care providers should be familiar with why and how VUSs are reported, their clinical significance, variant reclassification practices, and patient perceptions of VUSs.

obstetrics & gynecology
Understanding genetic variants in context

Christine Queitsch,Cole Trapnell,Douglas M Fowler,Frederick Roth,Judit Villen,Lea M Starita,Nasa Sinnott-Armstrong,Stanley Fields

DOI: https://doi.org/10.7554/elife.88231

IF: 7.7

2024-12-04

eLife

Abstract:Over the last three decades, human genetics has gone from dissecting high-penetrance Mendelian diseases to discovering the vast and complex genetic etiology of common human diseases. In tackling this complexity, scientists have discovered the importance of numerous genetic processes – most notably functional regulatory elements – in the development and progression of these diseases. Simultaneously, scientists have increasingly used multiplex assays of variant effect to systematically phenotype the cellular consequences of millions of genetic variants. In this article, we argue that the context of genetic variants – at all scales, from other genetic variants and gene regulation to cell biology to organismal environment – are critical components of how we can employ genomics to interpret these variants, and ultimately treat these diseases. We describe approaches to extend existing experimental assays and computational approaches to examine and quantify the importance of this context, including through causal analytic approaches. Having a unified understanding of the molecular, physiological, and environmental processes governing the interpretation of genetic variants is sorely needed for the field, and this perspective argues for feasible approaches by which the combined interpretation of cellular, animal, and epidemiological data can yield that knowledge.

biology
Experiences of individuals with a variant of uncertain significance on genetic testing for hereditary cancer risks: a mixed method systematic review

Danielle Gould,Rachel Walker,Grace Makari-Judson,Memnun Seven

DOI: https://doi.org/10.1007/s12687-022-00600-4

2022-07-13

Journal of Community Genetics

Abstract:The expansion of Multi-Gene Panel Testing (MGPT) has led to increased detection of variants of uncertain significance (VUS) among individuals with personal or family history of cancer. However, having a VUS result can impact on emotional and psychological wellbeing and cause challenges for non-geneticist healthcare providers. The purpose of this mixed methods systematic review was to examine what is currently known about the experiences of individuals with a VUS on genetic testing for inherited cancer susceptibility. The initial search was conducted in June 2020 using PUBMED, CINAHL, Web of Science, and PsychInfo according to the Joanna Briggs methodology for systematic reviews. A total of 18 studies met the inclusion criteria. Studies included in this review identified a range of emotional reactions to a VUS result, a general lack of understanding of a VUS result and its implications, frustration with a lack of healthcare provider knowledge, and a need for clear communication with healthcare providers. This review identified critical gaps in current knowledge to guide genetic counseling praxis, specifically in the knowledge of communication patterns and methods of improving communication with healthcare providers and family members and preferred risk management strategies. This will help to improve the counseling process and the management of care during and after genetic testing.
Enhancing Variant of Uncertain Significance (VUS) Interpretation in Neurogenetics: Collaborative Experiences from a Tertiary Care Centre

Kayla Horowitz,Nellie H. Fotopoulos,Alana J. Mistry,Justin Simo,Miranda Medeiros,Isabela D. Bucco,Mia Ginsberg,Emily Dwosh,Roberta La Piana,Guy A. Rouleau,Allison A. Dilliott,Sali M.K. Farhan

DOI: https://doi.org/10.1101/2024.05.13.24307186

2024-05-13

Abstract:The findings of variants of uncertain significance (VUS) on a clinical genetic testing report pose a challenge for attending healthcare professionals (HCPs) in patient care. Here, we describe the outcomes of multidisciplinary VUS Rounds, implemented at a neurological disease tertiary care centre, which aid in interpreting and communicating VUS identified in our neurogenetics patient population. VUS Rounds brought together genetic counsellors, molecular geneticists, and scientists to evaluate VUS against genomic and phenotypic evidence and assign an internal temperature classification "VUS Hot", "True VUS", or "VUS Cold", corresponding to potential pathogenicity. Biweekly meetings were held among the committee to deliberate variant classifications, determine additional clinical management actions, and discuss nuances of VUS result communication. In total, 143 VUS identified in 72 individuals with neurological disease were curated between October 2022 and December 2023. Of these, 12.6% were classified as VUS Hot, carried by 22.2% of the individuals, allowing for prioritization of additional evaluation to determine potential pathogenicity of the variants, such as clinical follow-up or segregation analysis. In contrast, 45.4% of VUS were Cold and could be eliminated from further consideration in the carrier's care. Herein, we thoroughly evaluated the various evidence that contributed to our VUS classifications and resulting clinical actions. The assessment of VUS leveraging multidisciplinary collaboration allowed us to delineate required follow-up analyses for our neurology patient population. Integration of VUS Rounds into healthcare practices, ensures equitable knowledge dissemination amongst HCPs and effective incorporation of uncertain genetic results into patient care.
Major Causes of Conflicting Interpretations of Variant Pathogenicity in Rare Disease: A Systematic Analysis

Tatyana E Lazareva,Yury A Barbitoff,Yulia A Nasykhova,Andrey S Glotov

DOI: https://doi.org/10.3390/jpm14080864

2024-08-15

Abstract:The identification of the genetic causes of inherited disorders from next-generation sequencing (NGS) data remains a complicated process, in particular due to challenges in interpretation of the vast amount of generated data and hundreds of candidate variants identified. Inconsistencies in variant classification, where genetic centers classify the same variant differently, can hinder accurate diagnoses for rare diseases. Publicly available databases that collect data on human genetic variations and their association with diseases provide ample opportunities to discover conflicts in variant interpretation worldwide. In this study, we explored patterns of variant classification discrepancies using data from ClinVar, a public archive of variant interpretations. We found that 5.7% of variants have conflicting interpretations (COIs) reported, and the vast majority of interpretation conflicts arise for variants of uncertain significance (VUS). As many as 78% of clinically relevant genes harbor variants with COIs, and genes with high COI rates tended to have more exons and longer transcripts, with a greater proportion of genes linked to several distinct conditions. The enrichment analysis of COI-enriched genes revealed that the products of these genes are involved in cardiac disorders, muscle development, and function. To improve diagnoses, we believe that specific variant interpretation rules could be developed for such genes. Additionally, our findings underscore the need for the publication of variant pathogenicity evidence and the importance of considering every variant as VUS unless proven otherwise.
Automated validation of genetic variants from large databases: ensuring that variant references refer to the same genomic locations

Mark Y. Tong,Christopher A. Cassa,Isaac S. Kohane

DOI: https://doi.org/10.1093/bioinformatics/btr029

IF: 5.8

2011-01-22

Bioinformatics

Abstract:SUMMARY: Accurate annotations of genomic variants are necessary to achieve full-genome clinical interpretations that are scientifically sound and medically relevant. Many disease associations, especially those reported before the completion of the HGP, are limited in applicability because of potential inconsistencies with our current standards for genomic coordinates, nomenclature and gene structure. In an effort to validate and link variants from the medical genetics literature to an unambiguous reference for each variant, we developed a software pipeline and reviewed 68 641 single amino acid mutations from Online Mendelian Inheritance in Man (OMIM), Human Gene Mutation Database (HGMD) and dbSNP. The frequency of unresolved mutation annotations varied widely among the databases, ranging from 4 to 23%. A taxonomy of primary causes for unresolved mutations was produced.AVAILABILITY: This program is freely available from the web site (http://safegene.hms.harvard.edu/aa2nt/).

biochemical research methods,biotechnology & applied microbiology,mathematical & computational biology
Exploring the factors affecting classification and reporting of uncertain prenatal microarray findings, using a "virtual fetus" model‐a pilot study

Rachel Michaelson‐Cohen,Liat Sheelo Salzer,Dana Brabbing‐Goldstein,Yuval Yaron,Adi Reches,Hagith Yonath,Miriam Regev,Hagit Shani,Gheona Altarescu,Reeval Segel,Rivka Sukenik‐Halevy,Hagit Daum,Tamar Harel,Vardiella Meiner,Lina Basel‐Salmon,Lena Sagi‐Dain,Idit Maya

DOI: https://doi.org/10.1002/pd.6535

2024-02-16

Prenatal Diagnosis

Abstract:Objective Significant discrepancy exists between laboratories in classification and reporting of copy number variants (CNVs). Studies exploring factors affecting prenatal CNV management are rare. Our "virtual fetus" pilot study examines these factors. Method Ten prenatally diagnosed CNVs of uncertain significance (VUS) > 1Mb, encompassing OMIM‐morbid genes, inherited from healthy parents, were classified by 15 MD geneticists from laboratory, prenatal, and preimplantation genetic testing (PGT) units. Geneticists addressed factors affecting classification, obligation to report, and recommendation for invasive testing or PGT. Results CNVs were classified likely benign (10.7%), VUS (74.7%), likely pathogenic (8.7%), or pathogenic (6.0%). Classification discrepancy was higher for losses versus gains. Classifying pathogenic/likely pathogenic was more common for losses (adjusted odds ratio [aOR] 10.9, 95% CI 1.55–76.9), and geneticists specializing in gynecology (aOR 4.9, 95% CI 1.03–23.3). 84.0% of respondents would report CNVs, depending on classification and family phenotype. Invasive testing in pregnancies was recommended for 29.3% of CNVs, depending on the classification and geneticist's specialization. PGT was recommended for 32.4%, depending on classification, experience years, and family's phenotype (38.0% for patients undergoing in vitro fertilization irrespectively, 26.7% otherwise). Conclusion Factors affecting CNV classification/reporting are mainly dosage, family phenotype, geneticist specialization and experience. Understanding factors from our pilot study may facilitate developing an algorithm for clinical consensus and optimal management.

genetics & heredity,obstetrics & gynecology
From variant to function in human disease genetics

Tuuli Lappalainen,Daniel G MacArthur,Daniel G. MacArthur

DOI: https://doi.org/10.1126/science.abi8207

IF: 56.9

2021-09-24

Science

Abstract:Over the next decade, the primary challenge in human genetics will be to understand the biological mechanisms by which genetic variants influence phenotypes, including disease risk. Although the scale of this challenge is daunting, better methods for functional variant interpretation will have transformative consequences for disease diagnosis, risk prediction, and the development of new therapies. An array of new methods for characterizing variant impact at scale, using patient tissue samples as well as in vitro models, are already being applied to dissect variant mechanisms across a range of human cell types and environments. These approaches are also increasingly being deployed in clinical settings. We discuss the rationale, approaches, applications, and future outlook for characterizing the molecular and cellular effects of genetic variants.

multidisciplinary sciences
Reasons and Resolutions for Inconsistent Variant Interpretation

Liling Lin,Hong Pan,Yu Qi,Yinan Ma,Ling Qiu

DOI: https://doi.org/10.1155/2023/4955235

2023-01-01

Human Mutation

Abstract:In the postgenomic era, variant interpretation is crucial for diagnosing monogenic diseases, which is the premise of precision medicine. The bottleneck and difficulty of genetic disease diagnosis have switched from the inaccessibility of detection technology to the interpretation of sequencing results. Multiple studies have suggested that the inconsistency rate of interlaboratory variant interpretation is approximately 10~40%. However, many clinicians have not paid enough attention to this area at present. In this review, we summarized the reasons for inconsistency, including classification methodology, information obtained by the interpreter, evidence application, and expert judgement. For clinicians, genetic counsellors, and molecular pathologists, it is necessary to reevaluate genetic reports, especially those supported by old literature and databases in clinical practice. For unresolvable cases, pedigree analysis, collaboration with research labs for functional experiments, and long-term follow-up to combine advanced clinical presentations with updated data and literature are needed.
Toward Automatic Variant Interpretation: Discordant Genetic Interpretation Across Variant Annotations for ClinVar Pathogenic Variants

Ann, Yu-An Chen,Tzu-Hang Yuan,Jia-Hsing Huang,Yu-Bin Wang,Tzu-Mao Hung,Chien-Yu Chen,Jacob Shujui Hsu,Pei-Lung Chen

DOI: https://doi.org/10.1101/2024.10.11.617756

2024-10-15

Abstract:Purpose: High-throughput sequencing has revolutionized genetic disorder diagnosis, but variant pathogenicity interpretation is still challenging. Even though the Human Genome Variation Society (HGVS) provides recommendations for variant nomenclature, discrepancies in annotation remain a significant hurdle. Methods: This study evaluated the annotation concordance between three tools-ANNOVAR, SnpEff, and Variant Effect Predictor (VEP)-using 164,549 two-star variants from ClinVar. The analysis used HGVS nomenclature string-match comparisons to assess annotation consistency from each tool, corresponding coding impacts, and associated ACMG criteria inferred from the annotations. Results: The analysis revealed variable concordance rates, with 58.52% agreement for HGVSc, 84.04% for HGVSp, and 85.58% for the coding impact. SnpEff showed the highest match for HGVSc (0.988), while VEP bettered for HGVSp (0.977). The substantial discrepancies were noted in the Loss-of-Function (LoF) category. Incorrect PVS1 interpretations affected the final pathogenicity and downgraded PLP variants (ANNOVAR 55.9%, SnpEff 66.5%, VEP 67.3%), risking false negatives of clinically relevant variants in reports. Conclusions: These findings highlight the critical challenges in accurately interpreting variant pathogenicity due to discrepancies in annotations. To enhance the reliability of genetic variant interpretation in clinical practice, standardizing transcript sets and systematically cross-validating results across multiple annotation tools is essential.

Genomics
An Evolutionary Perspective on the Impact of Genomic Copy Number Variation on Human Health

Marie Saitou,Omer Gokcumen

DOI: https://doi.org/10.1007/s00239-019-09911-6

2019-09-14

Journal of Molecular Evolution

Abstract:Copy number variants (CNVs), deletions and duplications of segments of DNA, account for at least five times more variable base pairs in humans than single-nucleotide variants. Several common CNVs were shown to change coding and regulatory sequences and thus dramatically affect adaptive phenotypes involving immunity, perception, metabolism, skin structure, among others. Some of these CNVs were also associated with susceptibility to cancer, infection, and metabolic disorders. These observations raise the possibility that CNVs are a primary contributor to human phenotypic variation and consequently evolve under selective pressures. Indeed, locus-specific haplotype-level analyses revealed signatures of natural selection on several CNVs. However, more traditional tests of selection which are often applied to single-nucleotide variation often have diminished statistical power when applied to CNVs because they often do not show strong linkage disequilibrium with nearby variants. Recombination-based formation mechanisms of CNVs lead to frequent recurrence and gene conversion events, breaking the linkage disequilibrium involving CNVs. Similar methodological challenges also prevent routine genome-wide association studies to adequately investigate the impact of CNVs on heritable human disease. Thus, we argue that the full relevance of CNVs to human health and evolution is yet to be elucidated. We further argue that a holistic investigation of formation mechanisms within an evolutionary framework would provide a powerful framework to understand the functional and biomedical impact of CNVs. In this paper, we review several cases where studies reveal diverse evolutionary histories and unexpected functional consequences of CNVs. We hope that this review will encourage further work on CNVs by both evolutionary and medical geneticists.

genetics & heredity,biochemistry & molecular biology,evolutionary biology
Missing genetic diversity impacts variant prioritisation for rare disorders

Samuel P. Tallman,Loukas Moutsianis,Thuy Nguyen,Yoonsu Cho,Maxine Mackintosh,Dalia Kasperaviciute,Matthew A. Brown,Jamie Ellingford,Karoline Kuchenbaecker,Matt J. Silver

DOI: https://doi.org/10.1101/2024.08.12.24311664

2024-08-14

Abstract:Whole genome sequencing identifies millions of genetic variants per individual. When applied to rare disease diagnosis, potentially pathogenic variants are prioritised for clinical interpretation, a process that may be influenced by an individuals genetic ancestry. We analysed millions of rare protein-altering variants prioritised in 29,425 participants with rare disease from the UK 100,000 Genomes Project. We observed disparities in the number of variants prioritised across genetic ancestry groups, with an up to 3-fold increase in participants with African compared to European ancestries. Variants prioritised in participants with non-European ancestries were less likely to be assessed as pathogenic. Leveraging a cohort of 34,701 diverse genomes from the UK, we identified thousands of candidate variants that were ultra-rare or unobserved across populations in gnomAD but common among ancestry-matched individuals. Our findings highlight the importance of using reference databases that reflect patient genetic diversity when prioritising variants for rare disease diagnosis.
Assessing the function of genetic variants in candidate gene association studies

Timothy R. Rebbeck,Margaret Spitz,Xifeng Wu

DOI: https://doi.org/10.1038/nrg1403

IF: 59.581

2004-01-01

Nature Reviews Genetics

Abstract:Key Points A large proportion of genomic variation might be associated with human disease phenotypes. New approaches should improve our understanding of this variation and its functional significance. Because there is insufficient guidance for molecular epidemiologists to optimally select variants for an epidemiology study, methods that prioritize the choice of genetic variants need to be included in molecular epidemiological studies. Laboratory-based evidence about the functional significance of a genetic variant can provide the strongest evidence for the functional role of a genetic variant, but these studies are difficult to mount on the scale that may be required for characterizing all human genetic variants, and their results might not always reflect in vivo genotype function in humans. Novel approaches to assessing the function of genetic variants are required to provide molecular epidemiological association studies with the information that is required to choose candidate genes and variants in these genes for association studies, and to optimally interpret the results of observed associations. Novel experimental approaches that might be informative, include the HaploCHIP method, gene tagging, gene trapping, N -ethyl- N -nitrosourea (ENU) mutagenesis, proteomics methods and evaluation of epigenetic mechanisms that assess genotype function. Non-laboratory-based approaches for assessing SNP function should also be considered. These approaches include those that use evolutionary similarity or structural effects of genetic variants, such as those implemented in the SIFT, PolyPhen or CODDLE algorithms. Population and evolutionary genetics data can be directly incorporated into association studies to optimize the identification of genes that are causally related to disease risk. The 'set association' approach is one example of this method. We propose an algorithm that can be useful in determining when a genetic variant might be functionally significant. This algorithm can be applied in the design and interpretation of molecular epidemiological association studies to maximize the potential that truly causative associations can be identified.
The Quest for Genetic Sequence Variants Conferring Risk of Endometriosis

Sun‐Wei Guo

DOI: https://doi.org/10.1016/b978-0-12-816561-4.00006-5

2020-01-01

Abstract:In the last two decades, numerous genetic association studies, including genome-wide genetic association studies, aimed at identifying DNA variants conferring risk of endometriosis have been published, and many polymorphisms have been identified. However, each and every one of the identified polymorphisms invariably has a small, even minute, effect, explaining merely a minuscule percentage of the heritability. More disconcertingly, these publications have so far contributed little to our understanding of the pathogenesis or pathophysiology of endometriosis. As with many other complex diseases or traits, there has been a glaring gap between the estimated heritability of the disease and the disease risk variability that can be explained by the identified DNA variants, a phenomenon called “the missing heritability.” This chapter provides a primer on genetic studies of complex diseases such as endometriosis, explaining the methods for demonstration of genetic components for a disease, and methods to identify the genes or genetic variants. It also provides some explanations as to why a “missing heritability” problem also exists in endometriosis.
Genomic disparity impacts variant classification of cancer susceptibility genes in Turkish breast cancer patients

Nihat B. Agaoglu,Busra Unal,Connor P. Hayes,McKenzie Walker,Ozden Hatirnaz Ng,Levent Doganay,Nisan D. Can,Huma Q. Rana,Arezou A. Ghazani

DOI: https://doi.org/10.1002/cam4.6852

IF: 4.711

2024-02-04

Cancer Medicine

Abstract:Objective Turkish genome is underrepresented in large genomic databases. This study aims to evaluate the effect of allele frequency in the Turkish population in determining the clinical utility of germline findings in breast cancer, including invasive lobular carcinoma (ILC), mixed invasive ductal and lobular carcinoma (IDC‐L), and ductal carcinoma (DC). Methods Two clinic‐based cohorts from the Umraniye Research and Training Hospital (URTH) were used in this study: a cohort consisting of 132 women with breast cancer and a non‐cancer cohort consisting of 492 participants. The evaluation of the germline landscape was performed by analysis of 27 cancer genes. The frequency and type of variants in the breast cancer cohort were compared to those in the non‐cancer cohort to investigate the effect of population genetics. The variant allele frequencies in Turkish Variome and gnomAD were statistically evaluated. Results The genetic analysis identified 121 variants in the breast cancer cohort (actionable = 32, VUS = 89) and 223 variants in the non‐cancer cohort (actionable = 25, VUS = 188). The occurrence of 21 variants in both suggested a possible genetic population effect. Evaluation of allele frequency of 121 variants from the breast cancer cohort showed 22% had a significantly higher value in Turkish Variome compared to gnomAD (p

oncology
Guidelines for investigating causality of sequence variants in human disease

D. G. MacArthur,T. A. Manolio,D. P. Dimmock,H. L. Rehm,J. Shendure,G. R. Abecasis,D. R. Adams,R. B. Altman,S. E. Antonarakis,E. A. Ashley,J. C. Barrett,L. G. Biesecker,D. F. Conrad,G. M. Cooper,N. J. Cox,M. J. Daly,M. B. Gerstein,D. B. Goldstein,J. N. Hirschhorn,S. M. Leal,L. A. Pennacchio,J. A. Stamatoyannopoulos,S. R. Sunyaev,D. Valle,B. F. Voight,W. Winckler,C. Gunter

DOI: https://doi.org/10.1038/nature13127

IF: 64.8

2014-04-01

Nature

Abstract:Acceleration in discovery of rare genetic variants possibly linked with disease may mean an increased risk of false-positive reports of causality; this Perspective proposes guidelines to distinguish disease-causing sequence variants from the many potentially functional variants in a human genome, and to assess confidence in their pathogenicity, and highlights priority areas for development.

multidisciplinary sciences

Significance of Variants of Uncertain Significance: The Human Cost of Genetic Uncertainty

The Biggest Struggle: Navigating Trust and Uncertainty in Genetic Variant Interpretation

Family Lore, a Variant of Uncertain Significance, and CADASIL

Variant scoring performance across selection regimes depends on variant-to-gene and gene-to-disease components

Capturing All Disease-Causing Mutations for Clinical and Research Use: Toward an Effortless System for the Human Variome Project

Germline Variants of Uncertain Significance in Gynecologic Oncology Patients

Understanding genetic variants in context

Experiences of individuals with a variant of uncertain significance on genetic testing for hereditary cancer risks: a mixed method systematic review

Enhancing Variant of Uncertain Significance (VUS) Interpretation in Neurogenetics: Collaborative Experiences from a Tertiary Care Centre

Major Causes of Conflicting Interpretations of Variant Pathogenicity in Rare Disease: A Systematic Analysis

Automated validation of genetic variants from large databases: ensuring that variant references refer to the same genomic locations

Exploring the factors affecting classification and reporting of uncertain prenatal microarray findings, using a "virtual fetus" model‐a pilot study

From variant to function in human disease genetics

Reasons and Resolutions for Inconsistent Variant Interpretation

Toward Automatic Variant Interpretation: Discordant Genetic Interpretation Across Variant Annotations for ClinVar Pathogenic Variants

An Evolutionary Perspective on the Impact of Genomic Copy Number Variation on Human Health

Missing genetic diversity impacts variant prioritisation for rare disorders

Assessing the function of genetic variants in candidate gene association studies

The Quest for Genetic Sequence Variants Conferring Risk of Endometriosis

Genomic disparity impacts variant classification of cancer susceptibility genes in Turkish breast cancer patients

Guidelines for investigating causality of sequence variants in human disease